posted March 02, 2022 08:56 am by AviseAnalytics
(4)
$FOLD Amicus Therapeutics, Inc. (NASDAQ: FOLD), a biotechnology company developing cutting-edge therapeutics for treatment of rare metabolic diseases, announced that the proposed Business
...read more